Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Tonometric devices for central aortic systolic pressure measurements in patients with type 1 diabetes: comparison of the BPro and SphygmoCor devices

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Home blood pressure in pregnancy-the upper reference limit

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Self-monitoring of blood pressure during pregnancy: an observational study in the obstetrical waiting room

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Spontaneous blood pressure oscillations in mechanically ventilated patients with sepsis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. From pioneering to implementing automated blood pressure measurement in clinical practice: Thomas Pickering's legacy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Relation of cardiac adipose tissue to coronary calcification and myocardial microvascular function in type 1 and type 2 diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Describing the fecal metabolome in cryogenically collected samples from healthy participants

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Carotid-femoral pulse wave velocity is a risk marker for complications in persons with type 1 diabetes

    Publikation: KonferencebidragKonferenceabstrakt til konferenceForskning

Vis graf over relationer

OBJECTIVE: Central blood pressure may be a better risk marker than brachial blood pressure and can be measured noninvasively by tonometric devices. We investigate whether tonometric measurements are feasible in patients with diabetes and whether the degree of albuminuria or increased arterial stiffness affects measurements.

PATIENTS AND METHODS: In 676 patients with type 1 diabetes, comparison of central aortic systolic pressure (CASP) measurements by the BPro and the SphygmoCor devices were made. The BPro device can obtain both office and 24-h measurements, whereas the SphygmoCor device is an accepted device for CASP measurements.

RESULTS: Measurements of CASP with both BPro and SphygmoCor were available in 598 (88.5%) patients (mean age 54 years; mean diabetes duration 33 years; 45.2% women), and mean±SD of CASP was 122±17 and 118±17 mmHg, respectively (P<0.001). Linear and intraclass correlation coefficients between CASP estimated from BPro and SphygmoCor were r equal to 0.96 and 0.95 (P<0.001 for both). The mean±SD difference between devices was 3.6±4.8 mmHg (P<0.001).Analyses according to the level of albuminuria or degree of arterial stiffness were confirmatory.

CONCLUSION: In patients with type 1 diabetes, tonometric measurements of CASP with BPro and SphygmoCor showed strong correlations, although values differed by ∼4 mmHg between devices. Level of CASP, arterial stiffness, and degree of albuminuria did not interfere with the agreement between devices.In addition, the BPro device can obtain 24-h measurements and may thus be useful to assess the diurnal patterns of CASP.

OriginalsprogEngelsk
TidsskriftBlood Pressure Monitoring
Vol/bind18
Udgave nummer3
Sider (fra-til)156-60
Antal sider5
ISSN1359-5237
DOI
StatusUdgivet - jun. 2013
Eksternt udgivetJa

ID: 52006079